Paul M. Harari, MD Print Friendly PageChair, Department of Human Oncology
Faculty, University of Wisconsin School of Medicine and Public Health
Dr. Harari’s medical interests include radiation oncology, head and neck oncology, and oncology training and education.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Human Oncology|
Professional Certifications and Education
University of Arizona Medical Center
University of California-Davis Medical Center, Sacramento
University of Virginia School of Medicine, Charlottesville, VA, 1984
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Dr. Harari's clinical and laboratory research focuses on treatment advances for head and neck cancer patients through precision radiation techniques and the use of molecular targeted growth inhibitors combined with radiation.
Iyer G Price J Bourgeois S Armstrong E Huang S Harari PM .
Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab. BMC Cancer. 2016 Dec 1;16(1):928
[PubMed ID: 27905891]
Brower JV Chen S Bassetti MF Yu M Harari PM Ritter MA Baschnagel AM .
Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):985-993
[PubMed ID: 27869098]
Fayette J Wirth L Oprean C Udrea A Jimeno A Rischin D Nutting C Harari PM Csoszi T Cernea D O'Brien P Hanley WD Kapp AV Anderson M Penuel E McCall B Pirzkall A Vermorken JB .
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). Front Oncol. 2016 Oct 31;6:232
[PubMed ID: 27843803]
Iyer G Price J Bourgeois S Armstrong E Huang S Harari PM .
Insulin growth factor 1 like receptor (IGF-1R). BMC Cancer. 2016 Oct 6;16(1):773
[PubMed ID: 27716204]
Barasch S Mohindra P Hennrick K Hartig GK Harari PM Yang DT .
Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes. Am J Surg Pathol. 2016 Sep;40(9):1261-9
[PubMed ID: 27186851]
Bonner JA Giralt J Harari PM Baselga J Spencer S Bell D Raben D Liu J Schulten J Ang KK Rosenthal DI .
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial. Eur J Cancer. 2016 Sep;64:1-11
[PubMed ID: 27323346]
Bonner J Giralt J Harari P Spencer S Schulten J Hossain A Chang SC Chin S Baselga J .
Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):842-9
[PubMed ID: 27389475]
Morris ZS Saha S Magnuson WJ Morris BA Borkenhagen JF Ching A Hirose G McMurry V Francis DM Harari PM Chappell R Tsuji S Ritter MA .
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Cancer. 2016 Aug 15;122(16):2487-95
[PubMed ID: 27203227]
Bar-Ad V Zhang QE Harari PM Axelrod R Rosenthal DI Trotti A Jones CU Garden AS Song G Foote RL Raben D Shenouda G Spencer SA Harris J Le QT .
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience. Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1346-54
[PubMed ID: 27212198]
Divi V Harris J Harari PM Cooper JS McHugh J Bell D Sturgis EM Cmelak AJ Suntharalingam M Raben D Kim H Spencer SA Laramore GE Trotti A Foote RL Schultz C Thorstad WL Zhang QE Le QT Holsinger FC .
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer. 2016 Jul 15;
[PubMed ID: 27419843]
Morris ZS Guy EI Francis DM Gressett MM Werner LR Carmichael LL Yang RK Armstrong EA Huang S Navid F Gillies SD Korman A Hank JA Rakhmilevich AL Harari PM Sondel PM .
In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. Cancer Res. 2016 Jul 1;76(13):3929-41
[PubMed ID: 27197149]
Rosenthal DI Harari PM Giralt J Bell D Raben D Liu J Schulten J Ang KK Bonner JA .
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. J Clin Oncol. 2016 Apr 20;34(12):1300-8
[PubMed ID: 26712222]
Mohindra P Urban E Pagan JD Geye HM Patel VB Bayliss RA Bender ET Harari PM .
Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance. Head Neck. 2016 Apr;38(4):499-505
[PubMed ID: 25445257]
Francis DM Huang S Armstrong EA Werner LR Hullett C Li C Morris ZS Swick AD Kragh M Lantto J Kimple RJ Harari PM .
Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models. Clin Cancer Res. 2016 Feb 1;22(3):633-43
[PubMed ID: 26420857]
Wojcieszynski AP Rosenberg SA Brower JV Hullett CR Geurts MW Labby ZE Hill PM Bayliss RA Paliwal B Bayouth JE Harari PM Bassetti MF .
Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver. Radiother Oncol. 2016 Feb;118(2):416-8
[PubMed ID: 26627702]
Hoffman MR McCulloch TM Mohindra P Das R Geurts M Harari PM .
Simulation study of high-dose-rate brachytherapy for early glottic cancer. Brachytherapy. 2016 Jan-Feb;15(1):94-101
[PubMed ID: 26614234]
Yan Y Yadav P Bassetti M Du K Saenz D Harari P Paliwal BR .
Dosimetric differences in flattened and flattening filter-free beam treatment plans. J Med Phys. 2016 Apr-Jun;41(2):92-9
[PubMed ID: 27217620]
Huang S Peter Rodemann H Harari PM .
Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology. Recent Results Cancer Res. 2016;198:45-87
[PubMed ID: 27318681]
Britt CJ Stein AP Patel PN Harari PM Hartig GK .
Incidental Parotid Neoplasms: Pathology and Prevalence. Otolaryngol Head Neck Surg. 2015 Oct;153(4):566-8
[PubMed ID: 26019135]
Werner LR Huang S Francis DM Armstrong EA Ma F Li C Iyer G Canon J Harari PM .
Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors. Mol Cancer Ther. 2015 Sep;14(9):1994-2003
[PubMed ID: 26162687]